bectumomab

Known as: IMMU-LL2-Fab, MAb LL2 (EPB2), monoclonal antibody IMMU-LL2-Fab 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Immunization is the process of stimulating the body’s immunity against certain infectious diseases by administering vaccines… (More)
Is this relevant?
2009
2009
Diffuse Large B-Cell Lymphomas (DLBCLs) are the most common histologic subtype within non-Hodgkin’s lymphomas (NHLs), accounting… (More)
Is this relevant?
2008
2008
On January 1, 2000, Medicare extended the coverage of immunosuppression medications from 3 years to life for elderly and disabled… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2004
2004
Mangeat B, Turelli P, Caron G, et al. Nature. 2003;424:99–102 Innate intracellular antiretroviral defense mechanisms have been… (More)
Is this relevant?
2004
2004
Critical analysis of the immunological self/non-self model and of its implicit metaphysical foundations. An examination of the… (More)
Is this relevant?
2002
2002
UNLABELLED The efficacy of a Tc99m-labeled anti-lymphoma antibody fragment, bectumomab [LymphoScan], was retrospectively examined… (More)
Is this relevant?
1993
1993
In the last 20 years an unusually high incidence of acute promy-elocytic leukemia (APL) has been observed at the Monza pediatric… (More)
  • table 1
  • table 2
Is this relevant?
1993
1993
The advent of the first radioimmunoassays in the late 1950s and early '60s allowed routine measurement of low hormone… (More)
Is this relevant?
Highly Cited
1988
Highly Cited
1988
We have demonstrated that one Fc receptor for IgG (FcR) (CD16) on cultured human monocytes appears to be a developmentally… (More)
  • figure 2
  • figure 3
  • table I
  • table II
  • figure 5
Is this relevant?